 | • レポートコード：MRC2310A026 • 出版社/出版日：Persistence Market Research / 2023年6月 • レポート形態：英文、PDF、258ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,140,000 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,590,000 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 舌下アレルギー免疫療法市場：レポート範囲 Persistence Market Research社の最新レポート「舌下アレルギー免疫療法の世界市場」は、市場機会と現在の市場展望を評価し、市場に影響を与える対応セクションに関する詳細な分析と最新情報を提供します。この調査レポートは、市場の促進要因、阻害要因、動向、機会を含む現在の市場ダイナミクスに関する詳細な洞察を提供します。市場調査の主な目的は、2023年から2033年の予測期間中に市場がどのように推移するかについての独占情報を提示することです。 市場の成功成長のための重要な指標は、市場の前年比（YoY）成長分析、複合年間成長率（CAGR）を含むこの包括的なレポートで提示され、Persistence Market Research社の調査で網羅的に説明されています。この調査研究は、舌下アレルギー免疫療法薬の需要と調査期間中の定量的な開発機会を知る読者を支援することができます。 この調査レポートは、投資家、メーカー、サービスプロバイダー、流通業者、サプライヤーなど、ランドスケープに関わる株主にとって有益であり、舌下アレルギー免疫療法市場で繁栄するための適切な事業戦略の策定に役立ちます。舌下アレルギー免疫療法市場の株主、業界専門家、投資家、研究者、記者、ビジネス愛好家は、このPersistence Market Researchの調査レポートで紹介されている洞察や情報を活用することができます。 市場統計、ならびに舌下アレルギー免疫療法市場のビジネスシナリオに影響を与えるマクロ経済変数およびマクロ経済変数に関連する情報も、本調査に含まれています。市場の潜在的な発展に応じて、実質的な洞察もこのレポートで遭遇します。さらに、本レポートで提出されたデータにより、業界のマイナー企業や新規参入企業は、市場での牽引力を獲得するために適切な企業選択を行う際に役立ちます。 主要市場セグメント： Persistence Market Research社の舌下アレルギー免疫療法市場に関する調査レポートは、薬剤、適応症、アレルゲン、流通チャネル、地域の5つの重要なセグメントに分けた情報を提供しています。本レポートでは、これらのカテゴリに関連する重要な市場ダイナミクスと成長パラメータに関する包括的なデータと情報を提供します。 カテゴリー詳細: ・薬剤別： - オダクトラ - グラステック - ラグウィテック - オーラルエアー - アクテア - その他 ・疾患別： - アレルギー性鼻炎 - アレルギー性喘息 - 食物アレルギー - アトピー性皮膚炎 - その他 ・アレルゲン別： - 花粉 - 草の花粉 - 雑草花粉 - 木の花粉 - ダニ - カビ - 動物のふけ - 蜂毒 - ゴキブリ・昆虫 - その他 ・販売チャネル別： - 機関販売 - 政府病院 - 準政府系病院 - 民間病院 - 小売販売 - 小売薬局 - ドラッグストア - オンライン薬局 ・地域別： - 北米 - 中南米 - ヨーロッパ - 南アジア - 東アジア - オセアニア - 中東・アフリカ（MEA） レポート中の主な質問： 今後数年間、舌下アレルギー免疫療法で最も収益性の高い市場であり続けるのはどの地域ですか？ トレンドの変化は市場にどのような影響を与えるでしょうか？ COVID-19危機は市場成長にどのような影響を与えましたか？ 市場プレイヤーは先進地域の低空飛行チャンスをどのように捉えることができますか？ 市場関係者はどのような戦略を立てていますか？ 投資家が市場に投資する際に注意すべき、また取り組む可能性のある阻害要因にはどのようなものが挙げられますか？ 市場に影響を与える開発動向はどのようなことが挙げられますか？ 舌下アレルギー免疫療法市場に参入する企業は、先進国および新興国の成長機会をどのように活用できますか？ 調査方法： Persistence Market Research社の調査レポートでは、舌下アレルギー免疫療法市場の成長に関する広範な調査を実施し、市場の今後の成長パラメータに関する結論を得るために、独自の調査手法を活用しています。この調査手法は、一次調査と二次調査を組み合わせたもので、アナリストが結論の正確性と信頼性を確保するのに役立ちます。 市場調査作成時にアナリストが参照した二次資料には、政府機関の統計、業界誌、白書、社内外の独自データベースなどがあります。アナリストは、一次資料として本レポートの作成に貢献したシニアマネージャー、製品ポートフォリオマネージャー、CEO、副社長、マーケティング/プロダクトマネージャー、マーケットインテリジェンスマネージャーにインタビューを行いました。 一次および二次リソースから取得した包括的な情報は、市場の企業からの検証として機能し、舌下アレルギー免疫療法市場の成長見通しに関するPersistence Market Research社の予測をより正確で信頼性の高いものにしています。 |
1.エグゼクティブサマリー
2.市場概要
3.主要市場動向
4.付加価値洞察
5.世界の舌下アレルギー免疫療法市場-需要分析2015～2022年・予測2023～2033年
6.世界の舌下アレルギー免疫療法市場-価格分析
7.世界の舌下アレルギー免疫療法市場-バリュー分析2015～2022年・予測2023～2033年
8.市場背景
9.世界の舌下アレルギー免疫療法市場：薬剤別分析2015～2022年・予測2023～2033年
10.世界の舌下アレルギー免疫療法市場：疾患別分析2015～2022年・予測2023～2033年
11.世界の舌下アレルギー免疫療法市場：アレルゲンタイプ別分析2015～2022年・予測2023～2033年
12.世界の舌下アレルギー免疫療法市場：流通チャネル別分析2015～2022年・予測2023～2033年
13.世界の舌下アレルギー免疫療法市場：地域別分析2015～2022年・予測2023～2033年
14.北米の舌下アレルギー免疫療法市場：分析2015～2022年・予測2023～2033年
15.中南米の舌下アレルギー免疫療法市場：分析2015～2022年・予測2023～2033年
16.ヨーロッパの舌下アレルギー免疫療法市場：分析2015～2022年・予測2023～2033年
17.東アジアの舌下アレルギー免疫療法市場：分析2015～2022年・予測2023～2033年
18.南アジアの舌下アレルギー免疫療法市場：分析2015～2022年・予測2023～2033年
19.オセアニアの舌下アレルギー免疫療法市場国別：分析2015～2022年・予測2023～2033年
20.中東・アフリカの舌下アレルギー免疫療法市場国別：分析2015～2022年・予測2023～2033年
21.市場構造分析
22.競合分析
23.前提条件・略語
24.調査方法
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value Added Insights
4.1. Epidemiology of Key Indication, By Region
4.2. Product Adoption/Usage Analysis
4.3. Pipeline Assessment
4.4. Regulatory Scenario
4.5. Reimbursement Landscape
4.6. PESTLE Analysis
4.7. PORTER Analysis
4.8. Latest Industry Deals/M&A
5. Global Market Demand Analysis 2015-2022 and Forecast, 2023-2033
5.1. Historical Market Volume (Units) Analysis, 2015-2022
5.2. Current and Future Market Volume (Units) Projections, 2023-2033
5.2.1. Y-o-Y Growth Trend Analysis
6. Global Market – Pricing Analysis
6.1. Regional Pricing Analysis By Drug
6.2. Global Average Pricing Analysis Benchmark
6.3. Pricing Assumptions
7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2015-2022 and Forecast, 2023-2033
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2022
7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Market Background
8.1. Macro-Economic Factors
8.1.1. Global GDP Growth Outlook
8.1.2. Global Healthcare GDP Growth Overview
8.1.3. Global Geriatric Population
8.1.4. Global R&D Funding and Infrastructure Investment
8.1.5. Global Allergy Immunotherapy Market Overview
8.2. Forecast Factors – Relevance & Impact
8.2.1. Rising Prevalence Asthma.
8.2.2. Increasing Awareness for food allergy.
8.2.3. Increasing Healthcare Spending.
8.2.4. Rising focus on strengthening of immune system
8.2.5. Rising geriatric population
8.2.6. Rise In industrialization in regions
8.2.7. Rise of population due to industrial waste
8.2.8. Research and development in immunotherapeutic drugs.
8.3. Market Dynamics
8.3.1. Drivers
8.3.2. Restraints
8.3.3. Opportunity Analysis
9. Global Market Analysis 2015-2022 and Forecast 2023-2033, by Drug
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Drug, 2015-2022
9.3. Current and Future Market Size (US$ Mn) and Volume (Units) and Trend Analysis and Forecast By Drug, 2023-2033
9.3.1. ODACTRA
9.3.2. GRASTEK
9.3.3. RAGWITEK
9.3.4. ORALAIR
9.3.5. ACTAIR
9.3.6. Others
9.4. Market Attractiveness Analysis By Drug
10. Global Market Analysis 2015-2022 and Forecast 2023-2033, by Indication
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2015-2022
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2023-2033
10.3.1. Allergic Rhinitis
10.3.2. Allergic Asthma
10.3.3. Food Allergy
10.3.4. Atopic Dermatitis
10.3.5. Others
10.4. Market Attractiveness Analysis By Indication
11. Global Market Analysis 2015-2022 and Forecast 2023-2033, by Allergan Type
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Trend Analysis By Allergan Type, 2015-2022
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Allergan Type, 2023-2033
11.3.1. Pollens
11.3.2. House Dust Mites (HDM)
11.3.3. Mould
11.3.4. Animal Dander
11.3.5. Bee Venom
11.3.6. Cockroaches/Insects
11.3.7. Others
11.4. Market Attractiveness Analysis By Allergan Type
12. Global Market Analysis 2015-2022 and Forecast 2023-2033, by Distribution Channel
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2015-2022
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2023-2033
12.3.1. Institutional Sales
12.3.1.1. Gov. Hospitals
12.3.1.2. Semi-Gov. Hospitals
12.3.1.3. Private Hospitals
12.3.2. Retail Sales
12.3.2.1. Retail Pharmacy
12.3.2.2. Drug Stores
12.3.2.3. Online Pharmacy
12.4. Market Attractiveness Analysis By Distribution Channel
13. Global Market Analysis 2015-2022 and Forecast 2023-2033, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2015-2022
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2023-2033
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America Market Analysis 2015-2022 and Forecast 2023-2033
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2022
14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023-2033
14.3.1. By Country
14.3.1.1. U.S.
14.3.1.2. Canada
14.3.2. By Drug
14.3.3. By Indication
14.3.4. By Allergan Type
14.3.5. By Distribution Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Drug
14.4.3. By Indication
14.4.4. By Allergan Type
14.4.5. By Distribution Channel
14.5. Market Trends
14.6. Drivers and Restraints – Impact Analysis
14.7. Key Market Participants – Intensity Mapping
14.8. Country Level Analysis & Forecast
14.8.1. U.S. Market Analysis
14.8.1.1. .Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Drug
14.8.1.2.2. By Indication
14.8.1.2.3. By Allergan Type
14.8.1.2.4. By Distribution Channel
14.8.2. Canada Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Drug
14.8.2.2.2. By Indication
14.8.2.2.3. By Allergan Type
14.8.2.2.4. By Distribution Channel
15. Latin America Market Analysis 2015-2022 and Forecast 2023-2033
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2022
15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023-2033
15.3.1. By Country
15.3.1.1. Mexico
15.3.1.2. Brazil
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Drug
15.3.3. By Indication
15.3.4. By Allergan Type
15.3.5. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Drug
15.4.3. By Indication
15.4.4. By Allergan Type
15.4.5. By Distribution Channel
15.5. Market Trends
15.6. Drivers and Restraints – Impact Analysis
15.7. Key Market Participants – Intensity Mapping
15.8. Country Level Analysis & Forecast
15.8.1. Mexico Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Drug
15.8.1.2.2. By Indication
15.8.1.2.3. By Allergan Type
15.8.1.2.4. By Distribution Channel
15.8.2. Brazil Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Drug
15.8.2.2.2. By Indication
15.8.2.2.3. By Allergan Type
15.8.2.2.4. By Distribution Channel
15.8.3. Argentina Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Drug
15.8.3.2.2. By Indication
15.8.3.2.3. By Allergan Type
15.8.3.2.4. By Distribution Channel
16. Europe Market Analysis 2015-2022 and Forecast 2023-2033
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2022
16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023-2033
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. U.K.
16.3.1.3. France
16.3.1.4. Spain
16.3.1.5. Benelux
16.3.1.6. Russia
16.3.1.7. Italy
16.3.1.8. Rest of Europe
16.3.2. By Drug
16.3.3. By Indication
16.3.4. By Allergan Type
16.3.5. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Drug
16.4.3. By Indication
16.4.4. By Allergan Type
16.4.5. By Distribution Channel
16.5. Market Trends
16.6. Drivers and Restraints – Impact Analysis
16.7. Key Market Participants – Intensity Mapping
16.8. Country Level Analysis & Forecast
16.8.1. Germany Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Drug
16.8.1.2.2. By Indication
16.8.1.2.3. By Allergan Type
16.8.1.2.4. By Distribution Channel
16.8.2. U.K. Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Drug
16.8.2.2.2. By Indication
16.8.2.2.3. By Allergan Type
16.8.2.2.4. By Distribution Channel
16.8.3. France Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Drug
16.8.3.2.2. By Indication
16.8.3.2.3. By Allergan Type
16.8.3.2.4. By Distribution Channel
16.8.4. Spain Market Analysis
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast by Market Taxonomy
16.8.4.2.1. By Drug
16.8.4.2.2. By Indication
16.8.4.2.3. By Allergan Type
16.8.4.2.4. By Distribution Channel
16.8.5. BENELUX Market Analysis
16.8.5.1. Introduction
16.8.5.2. Market Analysis and Forecast by Market Taxonomy
16.8.5.2.1. By Drug
16.8.5.2.2. By Indication
16.8.5.2.3. By Allergan Type
16.8.5.2.4. By Distribution Channel
16.8.6. Russia Market Analysis
16.8.6.1. Introduction
16.8.6.2. Market Analysis and Forecast by Market Taxonomy
16.8.6.2.1. By Drug
16.8.6.2.2. By Indication
16.8.6.2.3. By Allergan Type
16.8.6.2.4. By Distribution Channel
16.8.7. Italy Market Analysis
16.8.7.1. Introduction
16.8.7.2. Market Analysis and Forecast by Market Taxonomy
16.8.7.2.1. By Drug
16.8.7.2.2. By Indication
16.8.7.2.3. By Allergan Type
16.8.7.2.4. By Distribution Channel
17. East Asia Market Analysis 2015-2022 and Forecast 2023-2033
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2022
17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023-2033
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Drug
17.3.3. By Indication
17.3.4. By Allergan Type
17.3.5. By Distribution Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Drug
17.4.3. By Indication
17.4.4. By Allergan Type
17.4.5. By Distribution Channel
17.5. Market Trends
17.6. Drivers and Restraints – Impact Analysis
17.7. Key Market Participants – Intensity Mapping
17.8. Country Level Analysis & Forecast
17.8.1. China Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Drug
17.8.1.2.2. By Indication
17.8.1.2.3. By Allergan Type
17.8.1.2.4. By Distribution Channel
17.8.2. Japan Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Drug
17.8.2.2.2. By Indication
17.8.2.2.3. By Allergan Type
17.8.2.2.4. By Distribution Channel
17.8.3. South Korea Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Drug
17.8.3.2.2. By Indication
17.8.3.2.3. By Allergan Type
17.8.3.2.4. By Distribution Channel
18. South Asia Market Analysis 2015-2022 and Forecast 2023-2033
18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2022
18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023-2033
18.3.1. By Country
18.3.1.1. India
18.3.1.2. Indonesia
18.3.1.3. Malaysia
18.3.1.4. Thailand
18.3.1.5. Rest of South Asia
18.3.2. By Drug
18.3.3. By Indication
18.3.4. By Allergan Type
18.3.5. By Distribution Channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Drug
18.4.3. By Indication
18.4.4. By Allergan Type
18.4.5. By Distribution Channel
18.5. Market Trends
18.6. Drivers and Restraints – Impact Analysis
18.7. Key Market Participants – Intensity Mapping
18.8. Country Level Analysis & Forecast
18.8.1. India Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Drug
18.8.1.2.2. By Indication
18.8.1.2.3. By Allergan Type
18.8.1.2.4. By Distribution Channel
18.8.2. Indonesia Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Drug
18.8.2.2.2. By Indication
18.8.2.2.3. By Allergan Type
18.8.2.2.4. By Distribution Channel
18.8.3. Malaysia Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Drug
18.8.3.2.2. By Indication
18.8.3.2.3. By Allergan Type
18.8.3.2.4. By Distribution Channel
18.8.4. Thailand Market Analysis
18.8.4.1. Introduction
18.8.4.2. Market Analysis and Forecast by Market Taxonomy
18.8.4.2.1. By Drug
18.8.4.2.2. By Indication
18.8.4.2.3. By Allergan Type
18.8.4.2.4. By Distribution Channel
19. Oceania Market 2015-2022 and Forecast 2023-2033
19.1. Introduction
19.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2022
19.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023-2033
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Drug
19.3.3. By Indication
19.3.4. By Allergan Type
19.3.5. By Distribution Channel
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Drug
19.4.3. By Indication
19.4.4. By Allergan Type
19.4.5. By Distribution Channel
19.5. Market Trends
19.6. Drivers and Restraints – Impact Analysis
19.7. Key Market Participants – Intensity Mapping
19.8. Country Level Analysis & Forecast
19.8.1. Australia Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Drug
19.8.1.2.2. By Indication
19.8.1.2.3. By Allergan Type
19.8.1.2.4. By Distribution Channel
19.8.2. New Zealand Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Drug
19.8.2.2.2. By Indication
19.8.2.2.3. By Allergan Type
19.8.2.2.4. By Distribution Channel
20. Middle East and Africa (MEA) Market Analysis 2015-2022 and Forecast 2023-2033
20.1. Introduction
20.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2022
20.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023-2033
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. South Africa
20.3.1.3. Türkiye
20.3.1.4. North Africa
20.3.1.5. Rest of MEA
20.3.2. By Drug
20.3.3. By Indication
20.3.4. By Allergan Type
20.3.5. By Distribution Channel
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Drug
20.4.3. By Indication
20.4.4. By Allergan Type
20.4.5. By Distribution Channel
20.5. Market Trends
20.6. Drivers and Restraints – Impact Analysis
20.7. Key Market Participants – Intensity Mapping
20.8. Country Level Analysis & Forecast
20.8.1. GCC Countries Market Analysis
20.8.1.1. Introduction
20.8.1.2. Market Analysis and Forecast by Market Taxonomy
20.8.1.2.1. By Drug
20.8.1.2.2. By Indication
20.8.1.2.3. By Allergan Type
20.8.1.2.4. By Distribution Channel
20.8.2. South Africa Market Analysis
20.8.2.1. Introduction
20.8.2.2. Market Analysis and Forecast by Market Taxonomy
20.8.2.2.1. By Drug
20.8.2.2.2. By Indication
20.8.2.2.3. By Allergan Type
20.8.2.2.4. By Distribution Channel
20.8.3. Türkiye Market Analysis
20.8.3.1. Introduction
20.8.3.2. Market Analysis and Forecast by Market Taxonomy
20.8.3.2.1. By Drug
20.8.3.2.2. By Indication
20.8.3.2.3. By Allergan Type
20.8.3.2.4. By Distribution Channel
20.8.4. North Africa Market Analysis
20.8.4.1. Introduction
20.8.4.2. Market Analysis and Forecast by Market Taxonomy
20.8.4.2.1. By Drug
20.8.4.2.2. By Indication
20.8.4.2.3. By Allergan Type
20.8.4.2.4. By Distribution Channel
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Concentration
21.4. Market Presence Analysis
22. Competition Analysis
22.1. Competition Dashboard
22.2. Branding and Promotional Strategies, By Key Players
22.3. Key Development Analysis
22.4. Competition Deep Dive
22.4.1. ALK Abello
22.4.1.1. Overview
22.4.1.2. Product Portfolio
22.4.1.3. Key Financials
22.4.1.4. Sales Footprint
22.4.1.5. SWOT Analysis
22.4.1.6. Strategy Overview
22.4.1.6.1. Marketing Strategy
22.4.1.6.2. Product Strategy
22.4.1.6.3. Channel Strategy
22.4.2. Stallergenes Greer
22.4.2.1. Overview
22.4.2.2. Product Portfolio
22.4.2.3. Key Financials
22.4.2.4. Sales Footprint
22.4.2.5. SWOT Analysis
22.4.2.6. Strategy Overview
22.4.2.6.1. Marketing Strategy
22.4.2.6.2. Product Strategy
22.4.2.6.3. Channel Strategy
22.4.3. Allergy Therapeutics
22.4.3.1. Overview
22.4.3.2. Product Portfolio
22.4.3.3. Key Financials
22.4.3.4. Sales Footprint
22.4.3.5. SWOT Analysis
22.4.3.6. Strategy Overview
22.4.3.6.1. Marketing Strategy
22.4.3.6.2. Product Strategy
22.4.3.6.3. Channel Strategy
22.4.4. Aimmune Therapeutics
22.4.4.1. Overview
22.4.4.2. Product Portfolio
22.4.4.3. Key Financials
22.4.4.4. Sales Footprint
22.4.4.5. SWOT Analysis
22.4.4.6. Strategy Overview
22.4.4.6.1. Marketing Strategy
22.4.4.6.2. Product Strategy
22.4.4.6.3. Channel Strategy
22.4.5. Biomay AG
22.4.5.1. Overview
22.4.5.2. Product Portfolio
22.4.5.3. Key Financials
22.4.5.4. Sales Footprint
22.4.5.5. SWOT Analysis
22.4.5.6. Strategy Overview
22.4.5.6.1. Marketing Strategy
22.4.5.6.2. Product Strategy
22.4.5.6.3. Channel Strategy
22.4.6. HAL Allergy group
22.4.6.1. Overview
22.4.6.2. Product Portfolio
22.4.6.3. Key Financials
22.4.6.4. Sales Footprint
22.4.6.5. SWOT Analysis
22.4.6.6. Strategy Overview
22.4.6.6.1. Marketing Strategy
22.4.6.6.2. Product Strategy
22.4.6.6.3. Channel Strategy
22.4.7. DBV Technologies
22.4.7.1. Overview
22.4.7.2. Product Portfolio
22.4.7.3. Key Financials
22.4.7.4. Sales Footprint
22.4.7.5. SWOT Analysis
22.4.7.6. Strategy Overview
22.4.7.6.1. Marketing Strategy
22.4.7.6.2. Product Strategy
22.4.7.6.3. Channel Strategy
22.4.8. Merck KGaA
22.4.8.1. Overview
22.4.8.2. Product Portfolio
22.4.8.3. Key Financials
22.4.8.4. Sales Footprint
22.4.8.5. SWOT Analysis
22.4.8.6. Strategy Overview
22.4.8.6.1. Marketing Strategy
22.4.8.6.2. Product Strategy
22.4.8.6.3. Channel Strategy
22.4.9. WOLWpharma
22.4.9.1. Overview
22.4.9.2. Product Portfolio
22.4.9.3. Key Financials
22.4.9.4. Sales Footprint
22.4.9.5. SWOT Analysis
22.4.9.6. Strategy Overview
22.4.9.6.1. Marketing Strategy
22.4.9.6.2. Product Strategy
22.4.9.6.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology
Table 01: Global Sublingual Allergy Immunotherapy Market Volume (Mn Units) Analysis and Opportunity Assessment 2015-2023, By RegionTable 02A: Global Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Drug
Table 02B: Global Sublingual Allergy Immunotherapy Market Volume (Units) Analysis and Forecast 2015-2033, by Drug
Table 03: Global Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Indication
Table 04: Global Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Allergen
Table 05: Global Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Distribution Channel
Table 06: North America Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
Table 07: North America Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Drug
Table 08: North America Sublingual Allergy Immunotherapy Market Volume (Units) Analysis and Forecast 2015-2033, by Drug
Table 09: North America Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Indication
Table 10: North America Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Allergen
Table 11: North America Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Distribution Channel
Table 12: Latin America Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
Table 13: Latin America Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Drug
Table 14: Latin America Sublingual Allergy Immunotherapy Market Volume (Units) Analysis and Forecast 2015-2033, by Drug
Table 15: Latin America Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Indication
Table 16: Latin America Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Allergen
Table 17: Latin America Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Distribution Channel
Table 18: Europe Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
Table 19: Europe Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Drug
Table 20: Europe Sublingual Allergy Immunotherapy Market Volume (Units) Analysis and Forecast 2015-2033, by Drug
Table 21: Europe Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Indication
Table 22: Europe Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Allergen
Table 23: Europe Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Distribution Channel
Table 24: South Asia Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
Table 25: South Asia Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Drug
Table 26: South Asia Sublingual Allergy Immunotherapy Market Volume (Units) Analysis and Forecast 2015-2033, by Drug
Table 27: South Asia Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Indication
Table 28: South Asia Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Allergen
Table 29: South Asia Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Distribution Channel
Table 30: East Asia Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
Table 31: East Asia Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Drug
Table 32: East Asia Sublingual Allergy Immunotherapy Market Volume (Units) Analysis and Forecast 2015-2033, by Drug
Table 33: East Asia Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Indication
Table 34: East Asia Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Allergen
Table 35: East Asia Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Distribution Channel
Table 36: Oceania Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
Table 37: Oceania Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Drug
Table 38: Oceania Sublingual Allergy Immunotherapy Market Volume (Units) Analysis and Forecast 2015-2033, by Drug
Table 39: Oceania Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Indication
Table 40: Oceania Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Allergen
Table 41: Oceania Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Distribution Channel
Table 42: Middle East & Africa Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
Table 43: Middle East & Africa Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Drug
Table 44: Middle East & Africa Sublingual Allergy Immunotherapy Market Volume (Units) Analysis and Forecast 2015-2033, by Drug
Table 45: Middle East & Africa Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Indication
Table 46: Middle East & Africa Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Allergen
Table 47: Middle East & Africa Sublingual Allergy Immunotherapy Market Value (US$ Mn) Analysis and Forecast 2015-2033, by Distribution Channel